JOFOC-Endotool-signed.pdf

DEPARTMENT OF VETERANS AFFAIRS

Justification for Single Source Awards IAW FAR 13.106-1

For Over Micro-Purchase Threshold but Not Exceeding the SAT ($250K)

Last update 2/01/2022 Page 1 of 2

Acquisition Plan Action ID: 36C249-23-AP-3282 .

Contracting Activity: Department of Veterans Affairs, Veterans Integrated Service Network (VISN) 09, Network Contracting Office (NCO) 9, Tennessee Valley Healthcare System (TVHS), Nashville Medical Center, 1310 24th Ave S, Nashville, Tennessee (TN) 37212. PR/2237: 626-24-1-200-0002

Brief Description of Supplies/ Services required and the intended use/Estimated Amount:

Monarch EndoTool® Glucose Management Software. Subscription renewal of the Monarch Medical EndoTool. This EndoTool software is a glucose management software system used in all patient care settings to recommend intravenous and subcutaneous transition dosing. The software adjusts and maintains the glucose level within a configurable clinician-determined target range. The Monarch Medical Endotool software is currently be utilized in 3 units at the TVHS Nashville campus covering 41 beds. Base and two one-year option total estimated amount: $191,032.84

Unique characteristics that limit availability to only one source, with the reason no other supplies or services can be used: The Monarch Medical Endotool has a feature that no other sources or products can provide. It has 11 patient specific physiological factors to provide clinical decision support in the dosing of insulin. Endotool is presently the only 3rd party electronic glycemic management system for decisional support of insulin titration that has VA Technical Reference Model approval for use within the Veterans Healthcare Administration (VHA). Other vendors such as Glytec Glucommander and GlucoStabilizer do not have TRM approval. Looking ahead for ensuring TVHS maintains and acquires systems that will remain compliant and interoperable with the new electronic health record (EHR), the business requirements for Office of Electronic Health Record Modernization (OEHRM) Electronic Glycemic Control Software (agnostic of vendors) have been defined and any system that is to interface with the new EHR will need to meet these business/clinical needs like Requirements Development and Management (RDM), a New Service Request Database (va.gov). The Monarch Endotool is the only source that has the Estimated Residual Extracellular Insulin (EREI) feature that allows for enhanced customization by constantly calculating the amount of residual insulin circulating in the blood stream and determining how much insulin is needed to ensure proper patient-specific dosing.

Description of market research conducted and results or statement why it was not conducted:

Market research was conducted using the following methods:

Reviewing the results of recent market research undertaken to meet similar or identical requirements;

Contacting knowledgeable individuals in Government and industry regarding market capabilities to meet requirements; Used VA’s VIP database to identify verified capable SDVOSBs and VOSBs; Querying the Government-wide database of contracts and other procurement instruments intended for use by multiple agencies available at www.contractdirectory.gov and other Government and commercial databases that provide information relevant to agency acquisitions; Reviewing catalogs and other generally available product literature published by manufacturers, distributors, and dealers or available on-line The results of market research identified Food & Drug Administration (FDA)-approved glucose management tools such as GlucoStabilizer, Glucommander, and EndoTool. TVHS for the

DEPARTMENT OF VETERANS AFFAIRS

Justification for Single Source Awards IAW FAR 13.106-1

For Over Micro-Purchase Threshold but Not Exceeding the SAT ($250K)

Last update 2/01/2022 Page 2 of 2 given in part 3. above determined the Monarch Medical Endotool product to be best suited for their glucose management process.

Contracting Officer's Certification: Purchase is approved in accordance with FAR13.106-1(b). I certify that the foregoing justification is accurate and complete to the best of my knowledge and belief.

Sascha Hertslet Digitally signed by Sascha Hertslet Date: 2023.08.31 10:01:17 -05'00'